These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1398234)

  • 21. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].
    Yue W; Yuan H; Mao XR; Deng YD; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):184-8. PubMed ID: 23967738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
    Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
    Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
    Lin ZQ; Fang F; Guo ZF; Chen Q
    Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.
    Huang Z; Zhao Z; Zheng Y; Peng L; Lin C; Deng H; Gao Z
    J Viral Hepat; 2013 Apr; 20 Suppl 1():52-7. PubMed ID: 23458525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.
    Pastore G; Santantonio T; Milella M; Monno L; Mariano N; Moschetta R; Pollice L
    J Hepatol; 1992 Mar; 14(2-3):221-5. PubMed ID: 1500686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients.
    He LT; Ye XG; Zhou XY
    World J Gastroenterol; 2016 Dec; 22(46):10210-10218. PubMed ID: 28028369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha2a (40 kda; PEGASYS).
    Chan HL; Wong VW; Chim AM; Wong GL; Chan HY; Sung JJ
    Antivir Ther; 2008; 13(4):555-62. PubMed ID: 18672534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High rates of HBsAg loss and seroconversion result from prolonged course of pegasys treatment].
    Li MH; Xie Y; Lu Y; Qiu GH; Liu F; Li XH; Zhao H; Song SJ; Guan XP; Cheng J; Xu DZ
    Zhonghua Gan Zang Bing Za Zhi; 2011 Mar; 19(3):182-5. PubMed ID: 21586235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.
    Rijckborst V; Hansen BE; Cakaloglu Y; Ferenci P; Tabak F; Akdogan M; Simon K; Akarca US; Flisiak R; Verhey E; Van Vuuren AJ; Boucher CA; ter Borg MJ; Janssen HL
    Hepatology; 2010 Aug; 52(2):454-61. PubMed ID: 20683945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
    Teuber G; Dienes HP; Meyer Zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1996 Apr; 34(4):230-6. PubMed ID: 8686350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
    Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
    Marinos G; Smith HM; Naoumov NV; Williams R
    Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy].
    Li MH; Hu LP; Zhang L; Lu Y; Shen G; Wu SL; Chang M; Mu CQ; Wu YZ; Yang M; Song SJ; Zhang SF; Hua WH; Xie Y; Cheng J; Xu DZ
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):826-31. PubMed ID: 26743242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.
    Han HL; Lang ZW
    World J Gastroenterol; 2003 Jan; 9(1):117-21. PubMed ID: 12508364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a Treatment.
    Li MH; Zhang L; Qu XJ; Lu Y; Shen G; Li ZZ; Wu SL; Liu RY; Chang M; Hu LP; Hua WH; Song SJ; Wan G; Xie Y
    Biomed Environ Sci; 2017 Mar; 30(3):177-184. PubMed ID: 28427487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors associated with HBeAg seroconversion in chronic hepatitis B patients treated with interferon alfa-2a].
    Li MH; Xie Y; Wu YZ; Xu DZ; Lu ZM; Hou JL; Jia JD; Wang YM; Zhang SL; Ren H; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):481-4. PubMed ID: 17669233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
    Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
    J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.